Sabby Management’s Cytori Therapeutics Inc Warrant CYTXW Stock Holding History

Sabby Management’s Portfolio CYTXW Stock Details CYTXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-37,793	Closed	–	–	157
2018 Q3	$0	Sell	37,793 -262,620	-87%	-$2.02K	﹤0.01%	163
2018 Q2	$3K	Buy	+300,413	New	+$5.17K	﹤0.01%	136
2018 Q1	–	Sell	-1,028,634	Closed	-$29.1K	–	231
2017 Q4	$11K	Sell	1,028,634 -209,318	-17%	-$5.57K	﹤0.01%	156
2017 Q3	$45K	Sell	1,237,952 -24,500	-2%	-$2.37K	﹤0.01%	151
2017 Q2	$454K	Buy	1,262,452 +805	+0.1%	+$357	0.03%	147
2017 Q1	$757K	Sell	1,261,647 -12,065	-0.9%	-$8.5K	0.04%	149
2016 Q4	$866K	Buy	1,273,712 +378,695	+42%	+$284K	0.05%	156
2016 Q3	$1.55M	Sell	895,017 -109,048	-11%	-$90.4K	0.06%	150
2016 Q2	$793K	Buy	+1,004,065	New	+$674K	0.04%	179

Sabby Management's CYTXW Position: Q4 2018 in Review

Sabby Management sold out of Cytori Therapeutics Inc Warrant (CYTXW) in Q4 2018, closing a stake of 37,793 shares.

Sabby Management first reported a position in CYTXW in Q2 2016 and held it in 9 quarters. The position peaked at $1.55M in Q3 2016. 0 funds tracked by Wall St. Rank hold CYTXW as of Q4 2018.

Sabby Management reported no remaining Cytori Therapeutics Inc Warrant position as of Q4 2018 after selling out during the quarter.
Sabby Management sold 37,793 Cytori Therapeutics Inc Warrant shares in Q4 2018.
Sabby Management first reported a position in Cytori Therapeutics Inc Warrant in Q2 2016 and held it in 9 quarters.
Sabby Management's Cytori Therapeutics Inc Warrant position peaked at $1.55M in Q3 2016.
0 funds tracked by Wall St. Rank held Cytori Therapeutics Inc Warrant as of Q4 2018.

Based on Sabby Management's 13F filing for Q4 2018, filed 14 Feb 2019.